Phase 1
N=59
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
Healthy
Bottom Line
View on ClinicalTrials.gov: NCT00645164 ↗Enrolled (actual)
59
Serious AEs
0.0%
Results posted
Apr 2009
Primary outcome: Primary: Frequency Distribution of Skin Irritation Scores — 39; 10; 3; 0 Scores on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 1
- Interventions
- Ointment Vehicle (Other); Xenaderm (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Healthpoint
- Primary completion
- May 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Frequency Distribution of Skin Irritation Scores |
39; 10; 3; 0; 0; 0 | — |
Summary
The product is being tested to see if exposure to light causes photoallergic reactions on the skin.
Eligibility Criteria
Inclusion Criteria
- Healthy subjects
Exclusion Criteria
- Less than 18 years
Data sourced from ClinicalTrials.gov (NCT00645164). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.